Edison issues update on NetScientific (NSCI)
November 30, 2018 09:39 ET
|
Edison Investment Research Limited
LONDON, Nov. 30, 2018 (GLOBE NEWSWIRE) -- In late November 2018, NetScientific (AIM: NSCI) announced that its portfolio company PDS Biotechnology and Edge Therapeutics (NASDAQ: EDGE) will merge. The...
Edison issues ADR update on Immutep (IMMP)
November 22, 2018 07:50 ET
|
Edison Investment Research Limited
LONDON, Nov. 22, 2018 (GLOBE NEWSWIRE) -- We expect Immutep (IMMP:US) to deliver on a number of important milestones in the year ahead. The AIPAC Phase II study of its APC activator eftilagimod...
Edison issues update on InMed Pharmaceuticals (IN)
November 21, 2018 04:26 ET
|
Edison Investment Research Limited
LONDON, Nov. 21, 2018 (GLOBE NEWSWIRE) -- InMed recently reported results for the first quarter of FY19 and continues to make solid progress in bringing INM-750 for epidermolysis bullosa (EB) into...
Edison issues update on Quantum Genomics (ALQGC)
November 13, 2018 06:19 ET
|
Edison Investment Research Limited
LONDON, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Quantum Genomics (ALQGC) released data from the Phase IIb NEW-HOPE trial, which strongly suggests that firibistat is an efficacious, safe drug with a...
Edison issues initiation on Auris Medical Holding (EARS)
November 01, 2018 12:00 ET
|
Edison Investment Research Limited
LONDON, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Auris Medical (EARS) is a clinical-stage biopharmaceutical company developing pharmacotherapies for neurologic disorders of the inner ear. The company’s...
Edison issues outlook on Probiodrug (PBD)
November 01, 2018 06:05 ET
|
Edison Investment Research Limited
LONDON, Nov. 01, 2018 (GLOBE NEWSWIRE) -- We believe one of the main reasons for the devaluation of Probiodrug’s (PBD) shares over the past year was the largely disappointing industry newsflow...
Edison issues ADR update on Kazia Therapeutics (KZIA)
October 29, 2018 09:29 ET
|
Edison Investment Research Limited
LONDON, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Kazia (KZIA) has added two further indications to the development program for its brain-penetrant PI3K inhibitor GDC-0084 through collaborations with...
Edison issues update on NetScientific (NSCI)
October 24, 2018 04:13 ET
|
Edison Investment Research Limited
LONDON, Oct. 24, 2018 (GLOBE NEWSWIRE) -- NetScientific (NSCI) announced the completion of a $10m Series A funding for Glycotest with Fosun Pharma, a Chinese pharmaceutical company with a market...
Edison issues update on NetScientific (NSCI)
October 19, 2018 05:49 ET
|
Edison Investment Research Limited
LONDON, Oct. 19, 2018 (GLOBE NEWSWIRE) -- NetScientific (NSCI) recently announced half-year results for 2018, with incremental progress continuing to be made, although we are yet to see that...
Edison issues initiation on Orège (OREGE)
October 17, 2018 10:15 ET
|
Edison Investment Research Limited
LONDON, United Kingdom, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Orège (OREGE) has developed a proprietary technology that reduces sludge treatment costs for clients by up to 80% and implies average...